|
|
| |
 |
Different mechanisms of cell entry by human-pathogenic Old and New World arenaviruses
|
|
|
Imported dengue hemorrhagic fever, Europe
Letter from Emerg Infect Dis, published online Jul 28
|
|
|
Potential vectors of Rift Valley fever in the Mediterranean region
From Vector-Borne Zoonotic Dis, published online Jul
|
|
|
Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya
From Emerg Infect Dis, published online Jul 23
|
|
|
Relationship between transmission intensity and incidence of dengue hemorrhagic fever in Thailand
From PLoS Negl Trop Dis, published online Jul 16
|
|
|
The enigma of yellow fever in East Africa
From Rev Med Virol, published online Jul 10
|
|
|
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
|
|
|
Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses
|
|
|
Case of yellow fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes
From J Infect Dis, published online Jul 3
|
|
|
Yellow fever vaccines and international travelers
From Jul Expert Rev Vaccines
|
|
|
A DNA vaccine for the prevention of Ebola virus infection
From Jun Curr Opin Mol Ther
|
|
|
Managing potential laboratory exposure to Ebola virus by using a patient biocontainment care unit
From Jun Emerg Infect Dis
|
|
|
Pressure-activated yellow fever 17DD virus: implications for vaccine development
|
|
|
Yellow fever-associated viscerotropic disease in Barcelona, Spain
From May-Jun J Travel Med
|
|
|
VHF: Current, comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis, treatment, and prophylaxis
CIDRAP-authored overview updated May 22 with new research
|
|
|
E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence
|
|
|
Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates
|
|
|
Human effector and memory CD+8 T-cell responses to smallpox and yellow fever vaccines
|
|
|
Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein
|
|
|
Intradermally administered yellow fever vaccine at reduced doses induces a protective immune response: a randomized controlled non-inferiority trial
From PLoS ONE, published online Apr 23
|
|
|
Lassa Fever
|
|
